Assessing the role of microRNAs in clinical severity of thalassemia patients, and in hydroxyurea mediated HbF induction | India Science, Technology & Innovation - ISTI Portal

×

Acces sibility Controls

Assessing the role of microRNAs in clinical severity of thalassemia patients, and in hydroxyurea mediated HbF induction

Implementing Organization

National Institute of Immunohaematology, Mumbai, Maharashtra

Principal Investigator

Dr. Anita Nadkarni

Scientist

|

National Institute of Immunohaematology, Mumbai, Maharashtra

Related Research

Quick Information

Area of Research

Life Sciences & Biotechnology

Focus Area

Thalassemia

Start Year

2017

Sanction Amount

₹ 51.88 L

Status

completed

Output

No. of Research Paper

00

Technologies (If Any)

00

No. of PhD Produced

N/A

Startup (If Any)

00

No. of Patents

Filed :00

Grant :00